Woebot Labs has created the world's first mental health chatbot supported by a controlled research trial. The global mental health care epidemic is growing at an unprecedented rate. Woebot was founded to address this crisis with tools to make therapy accessible and stigma-free for millions of people suffering from anxiety, depression and other serious mental health issues. Woebot demonstrated significant reduction in symptoms of depression and anxiety after a two week trial.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/01/18 | $8,000,000 | Series A |
AI Fund | undisclosed |
| 07/21/21 | $90,000,000 | Series B |
BlackRock Jazz Venture Partners  Kicker Ventures Mirae Asset Venture Investment Owl Ventures Temasek | undisclosed |
| 03/15/22 | $9,500,000 | Strategic |
Leaps by Bayer | undisclosed |
